Panacea Venture is a healthcare focused venture capital firm, with offices in Shanghai, Hong Kong, and Silicon Valley. Founded in 2017, Panacea Venture focuses on investing in and incubating early-stage life science companies with breakthrough technologies and discoveries that can potentially address unmet medical needs and enhance the quality of life on a global scale. We currently manage three USD funds and one RMB fund. Our investment team members are located across China, U.S., and Europe, with an extensive coverage of all the major global life sciences hubs.

The life science industry is fundamentally driven by innovation. Therefore, we actively seek for seminal research results, original ideas or invention, and the brightest minds and seasoned entrepreneurs that can help create and develop first-in-class or best-in-class therapeutics, medical devices, and diagnostics. We continue to anticipate and adapt to the changes of research, industry and regulatory trends, and remain constantly curious and inquisitive to new discoveries with clinical benefits and commercial potential.

With a very hands-on approach to the management of our portfolio companies, our investment strategy is focused and precise. Our professionals are often acting as members of the founding team. Utilizing our global network, we can bring in significant resources with deep industry experience and expertise to our portfolio companies. As a result, these companies are able to fully realize their intrinsic value and potential with multiple value inflection points and sustained competitiveness.